This message was sent to ##Email##
|
|
|
|
|
| |
AST
There are several opportunities to advance legislation with a direct impact on transplantation. You can make your voice heard by reaching out to your local representatives to encourage their support and sponsorship of the Comprehensive Immunosuppressive Drug Coverage for Kidney patients Act of 2016 and the Living Donor Protection Act. Visit the AST website to learn more about these legislative items and help raise awareness through an urgent request for grassroots support.
Contact your three Members of Congress and urge them to cosponsor & pass these important transplant community legislative initiatives. The preferred grassroots method to advance legislation is to personally make contact with your two U.S. Senators and U.S. House Representative. Information on identifying and accessing contact information for your representatives is available on the AST website for your convenience.
AST
Check out AST's archived webinars and journal clubs, and watch educational content when it's convenient for you. AST also offers a variety of resources for different transplant specialties, all available on our easy-to-search website.
AST
Dec. 7, 2016 1 PM Online Activity
For more information: https://www.myast.org/education/webinars/optimizing-your-living-kidney-donor-program
 |
|
Sanofi Genzyme supports physicians in solid organ transplant through:
• Ongoing support of major professional societies
• Medical education
• Fellows conferences
• Professional education for community physician groups
We are investing in the present and future of transplantation
|
|
AST
Dec. 12, 2016 2 p.m. Online Activity
For more information: https://www.myast.org/education/webinars/t3
CEOT
The theme of improving long-term outcomes is extending into AST's 2017 Cutting Edge of Transplantation (CEOT) meeting. We hope you will join us for “One Transplant for Life: Many Pathways to Success.” February 23-25 in Phoenix Arizona, being held at the beautiful Arizona Biltmore. Throughout the conference, individual sessions will focus on specific topic areas regarding donor organ survival including barriers to therapeutic innovation, enhanced measures of quality and value, tolerance, recipient candidacy and post-transplant infections, as well as policy topics such as the use of marginal organs.
ATC
The American Transplant Congress is designed for physicians, surgeons, scientists, nurses, organ procurement personnel and pharmacists who are interested in the clinical and research aspects of solid organ and tissue transplantation. The meeting will provide the most current information in the field of transplant science. The deadline to submit abstracts is today, Friday, December 2, 2016. For more information regarding abstract submission, please click here.
American Journal of Transplantation
Every 6 months, the Scientific Registry of Transplant Recipients (SRTR) publishes evaluations of every solid organ transplant program in the United States, including evaluations of 1-year patient and graft survival. The Centers for Medicare & Medicaid Services (CMS) and the Organ Procurement and Transplantation Network (OPTN) Membership and Professional Standards Committee (MPSC) use SRTR's 1-year evaluations for regulatory review of transplant programs.
READ MORE
American Journal of Transplantation
Modern medical care has irreversibly embraced outcomes monitoring, public reporting and transparency with patients, payers and regulators. Patients have come to expect accurate assessment of the potential risks and likely outcome of medical procedures. Similarly, medical professionals rely on outcomes data to drive health care innovation and improvement through critical evaluation of care processes.
READ MORE
American Journal of Transplantation
We and others have previously described signatures of tolerance in kidney transplantation showing the differential expression of B cell–related genes and the relative expansions of B cell subsets. However, in all of these studies, the index group—namely, the tolerant recipients—were not receiving immunosuppression (IS) treatment, unlike the rest of the comparator groups.
READ MORE
American Journal of Transplantation
The phrase "human–animal chimera" can evoke ancient
mythology and centaurs and mermaids. Within the world
of modern science, however, the phrase is applied to scientific advances that are neither monstrous nor terrifying.
In reality, a chimeric mouse looks, to the naked eye, like any
other mouse. Only the researcher knows that this mouse houses a
human immune system that allows for experiments that can provide
insights into human disease.
READ MORE
The Journal of Heart and Lung Transplantation
Prior coronary artery bypass grafting (CABG) has been a contraindication to lung transplantation (LTx) because of disease severity and technical considerations. Although patients increasingly are being referred for and receiving LTx, whether it should remain a contraindication is unknown. We sought to define the prevalence of LTx after CABG and determine the effect on outcomes.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
